User profiles for Alessio Mazzoni

Alessio Mazzoni

Verified email at unifi.it
Cited by 4216

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

A Mazzoni, L Salvati, L Maggi… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Coronavirus disease 19 (COVID-19) is an emerging infectious disease
caused by SARS-CoV-2. Antiviral immune response is crucial to achieve pathogen clearance; …

First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

A Mazzoni, N Di Lauria, L Maggi… - The Journal of …, 2021 - Am Soc Clin Investig
The characterization of the adaptive immune response to COVID-19 vaccination in individuals
who recovered from SARS-CoV-2 infection may define current and future clinical practice. …

[HTML][HTML] The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection

O Gallo, LG Locatello, A Mazzoni, L Novelli… - Mucosal …, 2021 - Elsevier
The novel coronavirus SARS-CoV-2 enters into the human body mainly through the ACE2 +
TMPRSS2+ nasal epithelial cells. The initial host response to this pathogen occurs in a …

Guidelines for the use of flow cytometry and cell sorting in immunological studies

…, RA Manz, MF Mashreghi, A Mazzoni… - European journal of …, 2021 - Wiley Online Library
The third edition of Flow Cytometry Guidelines provides the key aspects to consider when
performing flow cytometry experiments and includes comprehensive sections describing …

Distinctive features of classic and nonclassic (T h17 derived) human T h1 cells

…, MC Rossi, V Querci, A Mazzoni… - European journal of …, 2012 - Wiley Online Library
T helper17 ( T h17) lymphocytes represent a third arm of the CD 4 + T ‐cell effector responses,
in addition to T h1 and T h2 cells. T h17 cells have been found to exhibit high plasticity …

Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab

G Meoni, V Ghini, L Maggi, A Vignoli, A Mazzoni… - PLoS …, 2021 - journals.plos.org
The current pandemic emergence of novel coronavirus disease (COVID-19) poses a relevant
threat to global health. SARS-CoV-2 infection is characterized by a wide range of clinical …

Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study

…, A Berni, I Tassinari, L Zammarchi, L Maggi, A Mazzoni… - Leukemia, 2021 - nature.com
Overwhelming inflammatory reactions contribute to respiratory distress in patients with COVID-19.
Ruxolitinib is a JAK1/JAK2 inhibitor with potent anti-inflammatory properties. We report …

Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients

A Mazzoni, L Maggi, M Capone… - European Journal of …, 2020 - Wiley Online Library
The characterization of cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2
is fundamental to understand COVID‐19 progression and the development of …

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

A Mazzoni, A Vanni, M Spinicci… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19, occurs
via natural infection or vaccination. However, it is currently unknown how long infection- or …

Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion

A Mazzoni, L Salvati, L Maggi, F Annunziato… - Seminars in …, 2021 - Elsevier
One and half year following the occurrence of COVID-19 pandemic, significant efforts from
laboratories all over the world generated a huge amount of data describing the prototypical …